Drug and Market Development Publishing, Oct 2005, Pages: 124
... muscle) is associated with the prolongation of LQTS, and precipitation of a potentially-fatal arrhythmia known as Torsades de Pointes, hERG screening is taking ...
Select Biosciences Ltd, Feb 2009, Pages: 370
... Size -The Process of Drug Metabolism -Emerging Themes and Unmet Needs in the Toxicity Screening Marketplace -Stem Cells for Toxicity Screening hERG, LQTS, and ...
Biopharm Knowledge Publishing, March 2008, Pages: 116
... Determination of Cardiac Toxicity Professor D Terrar - Professor of Cardiac Electrophysiology, University of Oxford 5.0 In Vitro 5.1 hERG testing 5.1.1 ...
Drug and Market Development Publishing, Aug 2006, Pages: 100
... Determination of Cardiac Toxicity Professor D Terrar - Professor of Cardiac Electrophysiology, University of Oxford 5.0 In Vitro 5.1 hERG testing 5.1.1 ...
Decision Resources, Inc., May 2006, Pages: 21
... Capital Equipment and Consumable Budgets Market Size for Ion Channel Instrumentation: 2006, 2007, and 2008 hERG Liability Screening Market Metrics Types of Ion ...
John Wiley and Sons Ltd, Aug 2009, Pages: 533
... Ion-Channel Overview Function and Classification Many Potential Targets Undesirable Targets and HERG Few Marketed Ion-Channel Modulators - Screening Assays for ...
Informa Healthcare, Jan 2007, Pages: 236
... PART 4: Organ Specific Toxicity 14 Discovery Toxicology Screening: Predictive, In ... and In Vivo Approaches 16 Should cardiosafety be ruled by hERG inhibition? ...
Drug and Market Development Publishing, June 2006, Pages: 308
... Toxicogenomics High content screening Zebrafish Whole animal imaging Determining mutagenic and clastogenic potential Measuring HERG liability Investigating CYP ...
